Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 14/20 | 0.57 |
| ▸ | MMP2 | P08253 | 14/20 | 0.57 |
| ▸ | MMP9 | P14780 | 14/20 | 0.57 |
| ▸ | MMP13 | P45452 | 14/20 | 0.57 |
| ▸ | CA1 | P00915 | 13/20 | 0.57 |
| ▸ | CA2 | P00918 | 13/20 | 0.57 |
| ▸ | MMP8 | P22894 | 13/20 | 0.57 |
| ▸ | MMP3 | P08254 | 1/20 | 0.47 |
| ▸ | MMP7 | P09237 | 1/20 | 0.47 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.44 |
| ▸ | ABAT | P80404 | 1/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | NAT1 | P18440 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL849326 | 0.78 | SMN1; SMN2 (0.59) | MMP1MMP2MMP9MMP13CA1 | |
| SCHEMBL7542234 | 0.76 | SMN1; SMN2 (0.62) | MMP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL14368127 | 0.75 | CA1 (0.55) | MMP1MMP2MMP9MMP13CA1 | |
| SCHEMBL6276451 | 0.75 | FLT1 (0.67) | — | |
| SCHEMBL1859291 | 0.75 | ALDH1A1 (0.60) | MMP1MMP2MMP9MMP13CA1 | |
| SCHEMBL226161 | 0.75 | TDP1 (0.64) | MMP1MMP2MMP9MMP13MMP3 | |
| SCHEMBL27723796 | 0.75 | CA1 (0.64) | MMP1MMP2MMP9MMP13CA1 | |
| SCHEMBL6853680 | 0.74 | ALDH1A1 (0.48) | ALDH5A1ABATKDM4EALDH1A1 | |
| SCHEMBL2796555 | 0.74 | ALDH1A1 (0.56) | MMP1MMP2MMP9MMP13CA1 | |
| SCHEMBL2077386 | 0.74 | ALDH1A1 (0.63) | MMP1MMP2MMP9MMP13CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150011749-A1 | USE OF CERTAIN METAL-ACCUMULATING PLANTS FOR THE PERFORMANCE OF ORGANIC CHEMISTRY REACTIONS | UNIVERSITE MONTPELLIER 2 SCIENCES ET TECHNIQUES (FR) | 2015-01-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150011749-A1 | USE OF CERTAIN METAL-ACCUMULATING PLANTS FOR THE PERFORMANCE OF ORGANIC CHEMISTRY REACTIONS | ME1, OSGEP, AGL | MMP1 4407/4885MMP2 4523/4885MMP9 3818/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.